• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Intracranial Hemorrhage (1891); Muscle Weakness (1967); Paralysis (1997); Cognitive Changes (2551)
Event Date 07/23/2022
Event Type  Injury  
Event Description
It was reported that the patient had a deep brain stimulation (dbs) implant procedure and experienced intracranial bleeding and hemiparesis post-operatively.A computerized tomography (ct) scan confirmed subcortical bleeding near the lead site.The physician assessed that the device or procedure contributed to the patients complications.The patient was put in the intensive care unit (icu) for sedation and ventilation while waiting for recovery.
 
Event Description
It was reported that the patient had a deep brain stimulation (dbs) implant procedure and experienced intracranial bleeding and hemiparesis post-operatively.A computerized tomography (ct) scan confirmed subcortical bleeding near the lead site.The physician assessed that the device or procedure contributed to the patients complications.The patient was put in the intensive care unit (icu) for sedation and ventilation while waiting for recovery.
 
Manufacturer Narrative
Correction to initial mdr in field h6 patient codes.
 
Event Description
It was reported that the patient had a deep brain stimulation (dbs) implant procedure and experienced intracranial bleeding which resulted in hemiparesis and reduced cognitive abilities postoperatively.A computerized tomography (ct) scan confirmed subcortical bleeding near the lead site.The physician assessed that the device or procedure contributed to the patients complications.The patient was taken to the intensive care unit (icu) for sedation and ventilation while waiting for recovery.The device remains implanted.Additional information was received that clarified the hemiparesis symptom the patient experienced was paralysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key15262660
MDR Text Key298278168
Report Number3006630150-2022-04174
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7091846
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/25/2022
Initial Date FDA Received08/19/2022
Supplement Dates Manufacturer Received09/07/2022
10/11/2022
Supplement Dates FDA Received09/15/2022
11/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-